Patients were randomly assigned centrally in a 1:1 ratio , using a computer-based minimisation algorithm stratifying by risk of seminal vesicle invasion and centre to either the control group ( 64 Gy in 32 fractions , the standard dose at the time the trial was designed ) or the escalated-dose group ( 74 Gy in 37 fractions ) .